Acro Biomedical Co (ACBM) Stock Statistics & Valuation Metrics

Acro Biomedical Co has a market cap or net worth of $42.03K. The enterprise value is ―.

Acro Biomedical Co has 60,042,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Acro Biomedical Co’s return on equity (ROE) is -32.63 and return on invested capital (ROIC) is -3099.02%.

The current PE Ratio of Acro Biomedical Co is -17.02. Acro Biomedical Co’s PEG ratio is -0.20.

In the last 12 months, Acro Biomedical Co had revenue of 658.50K and earned -15.87M in profits. Earnings per share was -0.26.

In the last 12 months, operating cash flow was -67.15K and capital expenditures 0.00, giving a free cash flow of -67.15K billion.

Acro Biomedical Co pays an annual dividend of ―, resulting in a dividend yield of ―

Acro Biomedical Co upcoming earnings date is Feb 15, 2018, TBA Not Confirmed.

Acro Biomedical Co as a current ratio of 3.27, with Debt / Equity ratio of 5.29%

In the past 12 months, Acro Biomedical Co has paid 0.00 in taxes.

Acro Biomedical Co EV to EBITDA ratio is -17.03, with an EV/FCF ratio of -1.83K.

Acro Biomedical Co has $2.68K in cash and marketable securities with $0.00 in debt, giving a net cash position of $10.31K billion.

Gross margin is 21.34%, with operating margin of -2409.98%, and net profit margin of -2410.24%.

The average price target for Acro Biomedical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―